Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032
According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...
0 Reacties 0 aandelen 42 Views 0 voorbeeld
JogaJog https://jogajog.com.bd